Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Breaking Barriers in Obesity Care - Scaling a Primary Care Weight Management Program Statewide.
Journal: NEJM catalyst innovations in care delivery
Published: July 08, 2026
Childhood obesity management in primary care: Bridging guidelines and practice.
Journal: Obesity pillars
Published: September 28, 2025
Impact of a Community-Based Weight Management Program in a North Carolina Health Care System.
Journal: Family medicine
Published: March 08, 2023
Pharmacokinetic-Pharmacodynamic Characterization of Omadacycline against Haemophilus influenzae Using a One-Compartment In Vitro Infection Model.
Journal: Antimicrobial agents and chemotherapy
Published: December 06, 2019
Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Cefepime in an In Vitro Infection Model.
Journal: Antimicrobial agents and chemotherapy
Published: May 30, 2017
Bacterial Replication Rate Modulation in Combination with Antimicrobial Therapy: Turning the Microbe against Itself.
Journal: Antimicrobial agents and chemotherapy
Published: July 22, 2016
Relationship between Fosfomycin Exposure and Amplification of Escherichia coli Subpopulations with Reduced Susceptibility in a Hollow-Fiber Infection Model.
Journal: Antimicrobial agents and chemotherapy
Published: February 12, 2016
Pharmacokinetics-Pharmacodynamics of a Novel β-Lactamase Inhibitor, CB-618, in Combination with Meropenem in an In Vitro Infection Model.
Journal: Antimicrobial agents and chemotherapy
Published: December 08, 2015
Exploration of the Pharmacokinetic-Pharmacodynamic Relationships for Fosfomycin Efficacy Using an In Vitro Infection Model.
Journal: Antimicrobial agents and chemotherapy
Published: December 03, 2014
Relationship between ceftolozane-tazobactam exposure and selection for Pseudomonas aeruginosa resistance in a hollow-fiber infection model.
Journal: Antimicrobial agents and chemotherapy
Published: July 30, 2014
Pharmacological basis of β-lactamase inhibitor therapeutics: tazobactam in combination with Ceftolozane.
Journal: Antimicrobial agents and chemotherapy
Published: September 18, 2013
Relationship between ceftolozane-tazobactam exposure and drug resistance amplification in a hollow-fiber infection model.
Journal: Antimicrobial agents and chemotherapy
Published: June 19, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026